265 related articles for article (PubMed ID: 15496451)
1. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways.
Yasuda K; Ogawa Y; Yamane I; Nishikawa M; Takakura Y
J Leukoc Biol; 2005 Jan; 77(1):71-9. PubMed ID: 15496451
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the type of liposome involving cytokine production induced by non-CpG Lipoplex in macrophages.
Yasuda S; Yoshida H; Nishikawa M; Takakura Y
Mol Pharm; 2010 Apr; 7(2):533-42. PubMed ID: 20047296
[TBL] [Abstract][Full Text] [Related]
3. Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes.
Yasuda K; Ogawa Y; Kishimoto M; Takagi T; Hashida M; Takakura Y
Biochem Biophys Res Commun; 2002 Apr; 293(1):344-8. PubMed ID: 12054606
[TBL] [Abstract][Full Text] [Related]
4. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
6. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
[TBL] [Abstract][Full Text] [Related]
7. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and activation characteristics of naked plasmid DNA and its cationic liposome complex in human macrophages.
Yamane I; Nishikawa M; Takakura Y
Int J Pharm; 2005 Nov; 305(1-2):145-53. PubMed ID: 16219432
[TBL] [Abstract][Full Text] [Related]
9. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
12. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH
FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179
[TBL] [Abstract][Full Text] [Related]
13. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
[TBL] [Abstract][Full Text] [Related]
14. Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice.
Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M
J Gene Med; 2008 Apr; 10(4):392-9. PubMed ID: 18181219
[TBL] [Abstract][Full Text] [Related]
15. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock.
Sparwasser T; Miethke T; Lipford G; Erdmann A; Häcker H; Heeg K; Wagner H
Eur J Immunol; 1997 Jul; 27(7):1671-9. PubMed ID: 9247576
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
[TBL] [Abstract][Full Text] [Related]
17. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors.
Coller SP; Paulnock DM
J Leukoc Biol; 2001 Jul; 70(1):142-8. PubMed ID: 11435497
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
Anderson RB; Cianciolo GJ; Kennedy MN; Pizzo SV
J Leukoc Biol; 2008 Feb; 83(2):381-92. PubMed ID: 17967834
[TBL] [Abstract][Full Text] [Related]
20. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
Shoda LK; Kegerreis KA; Suarez CE; Mwangi W; Knowles DP; Brown WC
J Leukoc Biol; 2001 Jul; 70(1):103-12. PubMed ID: 11435492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
